Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Cost-containing strategies may improve medication taking behaviors in some patients (17)
January 1, 2025 Update: Judge Marston has issued a scheduling order in the Wegovy and GLP-1 drug litigation, addressing the manufacturers filing of motions to dismiss claims based on arguments that federal preemption shields them from failure-to-warn claims
The specialty clinics segment held a 13% share of the market in 2025 and is expected to grow at a CAGR of 11.7% during the projection period
Tirzepatide, a Dual GIP/GLP-1 Receptor Co-Agonist for the Treatment of Type 2 Diabetes with Unmatched Effectiveness Regrading Glycaemic Control and Body Weight Reduction. Cardiovascular Diabetology , vol
A neutrophil elastase inhibitor reduces cigarette smoke-induced remodelling of lung vessels
US$ 21.57
US$ 28.76
US$ 24.92
